Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Bipolar Disord. 2011 Aug;13(5-6):474–485. doi: 10.1111/j.1399-5618.2011.00941.x

Table 1.

Demographic characteristics of subjects with bipolar disorder (BD) (n = 10) and controls (n = 10)

Paired subjects Gender/Age (yrs) Postmortem delay (hrs) Cause of death Treatmenta
BD Control BD Control BD Control BD Control
1 M/72 M/72 22 43 Suicide Accident Drug free Drug free
2 F/44 F/49 19 40 Suicide Accident APS, BZD, mirtazapine Drug free
3 M/58 M/54 10 23 Suicide Accident APS, lamotrigine BZD
4 M/40 M/43 17 11 Suicide Accident BZD Drug free
5 M/27 M/30 10 11 Suicide Accident Drug free Cannabis
6 M/63 M/60 8 4 Suicide Natural BZD Drug free
7 M/64 M/61 23 23 Suicide Accident BZD, venlafaxine Drug free
8 M/57 M/55 22 22 Natural Natural Drug free Drug free
9 M/63 M/67 31 19 Natural Natural Drug free NSAID
10 F/73 F/74 3 19 Suicide Accident Drug free NSAID

M = male; F = female; APS = antipsychotics; BZD = benzodiazepines; NSAID = nonsteroidal anti-inflammatory drug. BD group (mean ± SD): age: 56 ± 15 yrs; postmortem delay (PMD): 16 ± 9 hrs; pH in the cerebellum (CB): 6.74 ± 0.24; pH in the prefrontal cortex (PFC): 6.59 ± 0.14; RNA integrity number (RIN) in the CB: 7.52 ± 0.46; RIN in the PFC: 6.40 ± 1.03. Control group (mean ± SD): age: 56 ± 14 yrs; PMD: 21 ± 12 hrs; pH in the CB: 6.77 ± 0.26; pH in the PFC: 6.92 ± 0.32; RIN in the CB: 7.90 ± 0.53; RIN in the PFC: 6.85 ± 0.40.

a

Treatment indicates results of toxicology analysis performed by the National Institute of Toxicology, Madrid, Spain.